People with blood groups A, B and AB at higher risk of type II diabetes than group O

Read more

Towards Holistic Healing

Read more

Potential of regenerative medicine

Read more

Ayurveda – A potential global medical system

Read more

Integrative medicine: An idea whose time has come

Read more

Slower revenue growth at 6-quarter low in Q3FY15: CRISIL Research

Read more

Type II diabetes treatment market value in Asia-Pacific to hit $10.5 billion by 2020: GBI Research

Read more

Forecast 2015

Read more

Novartis collaborates with Intellia Therapeutics and Caribou Biosciences

Read more

Jubilant Life Sciences appoints Gurpartap Singh Sachdeva as CEO

Read more